Skip to content
  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved

Half the Data: How Medicine Built Itself on the Male Body

by Wendy Hung | Jun 16, 2026

Women live longer than men. This fact is conserved in sickness, during famines, during epidemics, and even during starvation. But longevity is not the same as vitality, and the statistics behind this headline tell a much more complicated story. Despite outliving men in nearly every country, women spend a disproportionately larger share of their lives […]

Read More

The 140-Year-Old Cell Type That Might Crack Cancer

by Jodie Lunger | Jun 16, 2026

Everyone loves a dark horse story. Biotech, however, is one of the hardest arenas for spotting these overlooked contenders. Because therapeutic development is so capital-intensive, investors must make massive commitments years before pivotal clinical trials occur, long before it’s clear which technology will prevail. Within the cell therapy space specifically, investors are tracking a crucial […]

Read More

Soil Before Seed: When Cancer Metabolism Met the GLP-1 Era

by Shruti Nagaraja, Ph.D. | Jun 16, 2026

Introduction GLP-1 receptor agonists have transformed metabolism from a niche therapeutic area into one of biotechnology’s most commercially significant platforms. However, the story of metabolism in oncology began long before semaglutide and tirzepatide became household names. Cancer researchers have spent decades mapping the same biological systems that GLP-1s made commercially visible. Their work converged on […]

Read More

The Cost of Cure: Funding Rare Genetic Disease Innovation

by Yibing (Shirley) Yao | Jun 16, 2026

Rare Disease Is Not Rare Living with a severe but rare genetic disease is like fighting a long, exhausting war in secret—one that, no matter how brave the fight, ends in defeat. It’s especially so for patients with Fanconi anemia (FA), whose bodies fail to safeguard their own genetic material, DNA. In everyday life, we […]

Read More

The 140-Year-Old Cell Type That Might Crack Cancer

by Jodie Lunger | Jun 16, 2026

Everyone loves a dark horse story. Biotech, however, is one of the hardest arenas for spotting these overlooked contenders. Because therapeutic development is so capital-intensive, investors must make massive commitments years before pivotal clinical trials occur, long before it’s clear which technology will prevail. Within the cell therapy space specifically, investors are tracking a crucial […]

Read More

Half the Data: How Medicine Built Itself on the Male Body

by Wendy Hung | Jun 16, 2026

Women live longer than men. This fact is conserved in sickness, during famines, during epidemics, and even during starvation. But longevity is not the same as vitality, and the statistics behind this headline tell a much more complicated story. Despite outliving men in nearly every country, women spend a disproportionately larger share of their lives […]

Read More

Beyond Vaccines: The Expanding RNA-Lipid Nanoparticle Landscape

by Xingyu (Jasmine) Hu | December 22nd, 2025

Introduction Few scientific breakthroughs have reshaped modern medicine as dramatically as lipid nanoparticles (LNPs). Once a niche area in nucleic acid delivery research, these tiny lipid assemblies became the cornerstone of the world’s COVID-19 response. When Pfizer/BioNTech and Moderna deployed their mRNA–LNP vaccines in record time, they not only helped curb a global pandemic—they unveiled […]

Read More

‘Processing’ An Old and Evolving Challenge for Plant-Based Innovation

by Charlie Mineo | December 27th, 2025

In the U.S., the phrase ‘vegan proteins’ once conjured images of simple foods like nuts, beans, or tofu. But over the past 10 years, an array of plant-based alternatives have painted a different picture—one filled with imitation milk, eggs, and meat that closely mimic their animal-derived counterparts. These products have been successful thanks to food-tech […]

Read More

From Pandemics to Progress: A Survey of Venture Capital Investments in Infectious Disease

by Nicole Tanenbaum | October 11th, 2024

From the blow of the Black Death in medieval Europe, to the polio epidemics of the 20th century, and the widespread devastation caused by smallpox, pathogens have continually caused widespread morbidity and mortality. Today, several of these microbes feel like threats of the past. With advancements in controlling infectious diseases, vaccine-preventable deaths have dropped and […]

Read More

T Cell Engineering: Crafting Cellular Warriors Against Cancer

by Dr. Mehdi Soleymani Goloujeh | October 11th, 2024

Introduction to the Challenge of Cancer Cancer is one of the major global health issues, with its incidence steadily increasing and mortality rates on the rise, affecting millions of people each year. In 2022, approximately 20 million new cancer cases and nearly 9.7 million cancer-related deaths were reported worldwide. By 2050, cancer cases are projected […]

Read More

A New Era: Key Implications of the Inflation Reduction Act on the Healthcare and Biopharma Ecosystem

by Han Le | February 6, 2024

Jacqueline Racener was diagnosed with leukemia and prescribed a drug offering the hope of combating the cancer with only moderate side effects. However, upon learning that the annual cost would be $8,000, even with her Medicare insurance, Jacqueline opted to stop filling her prescription, hoping that the cancer would not progress further. With cancer drugs […]

Read More

Beyond Antibody Therapies: Novel Therapeutic Approaches to Combat Alzheimer’s Disease

by Nicole Koutsodendris | February 6, 2024

Alzheimer’s disease (AD) is a neurological disorder that affects nearly 6.7 million Americans over the age of 65. The widespread nature of this disease means that many people are impacted by it in some way, whether it is being diagnosed with the disorder, or caring for an afflicted friend or family member. Despite its high […]

Read More

Next »

To learn more about how BCBA can
help your business or organization,
please contact us at info@biotechconnectionbay.org

2026 © Biotech Connection - Bay Area, Inc., All Rights Reserved

Biotech Websites Design by Thomas Digital

  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved